Published in Hypertension on May 31, 2005
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med (2008) 3.36
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 1.78
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.73
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension (2008) 1.72
Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension (2014) 1.41
Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension (2011) 1.34
A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol (2012) 1.24
The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol (2010) 1.23
Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension (2011) 1.14
Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol (2010) 1.14
Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci (Lond) (2012) 1.14
Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension (2010) 1.13
Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens (2011) 1.13
Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol (2009) 1.10
Is inflammation the cause of pre-eclampsia? Biochem Soc Trans (2011) 1.09
Preeclampsia: long-term consequences for vascular health. Vasc Health Risk Manag (2015) 1.08
Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med (2008) 1.07
Tumor necrosis factor-α: regulation of renal function and blood pressure. Am J Physiol Renal Physiol (2013) 1.05
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep (2011) 1.02
Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressure. Am J Hypertens (2007) 1.02
Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia. Cardiovasc Hematol Agents Med Chem (2010) 1.02
Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol (2011) 1.01
TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion. Am J Physiol Renal Physiol (2010) 0.98
Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol (2012) 0.98
Is preeclampsia an autoimmune disease? Clin Immunol (2009) 0.98
Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta. Am J Physiol Heart Circ Physiol (2010) 0.97
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf) (2013) 0.96
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens (2009) 0.95
Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. Hypertension (2012) 0.93
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol (2015) 0.92
IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? Int J Interferon Cytokine Mediat Res (2011) 0.91
Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension (2014) 0.90
Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol (2012) 0.90
Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda) (2013) 0.89
The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond) (2016) 0.87
Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc Hematol Disord Drug Targets (2010) 0.87
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol (2009) 0.86
Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia. Hypertension (2013) 0.86
Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol (2013) 0.86
Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol (2015) 0.86
Tumor necrosis factor-α receptor type 1, not type 2, mediates its acute responses in the kidney. Am J Physiol Renal Physiol (2012) 0.85
Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol (2008) 0.84
TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice. Am J Physiol Renal Physiol (2013) 0.84
Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia. Front Pharmacol (2014) 0.83
The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol (2014) 0.83
New approaches for managing preeclampsia: clues from clinical and basic research. Clin Ther (2014) 0.83
Immune Mechanisms Linking Obesity and Preeclampsia. Biomolecules (2015) 0.81
An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol (2015) 0.80
Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy. Curr Bioact Compd (2010) 0.80
Placental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-α. Am J Physiol Regul Integr Comp Physiol (2015) 0.79
Adaptive regulation of endothelin receptor type-A and type-B in vascular smooth muscle cells during pregnancy in rats. J Cell Physiol (2014) 0.77
IL-27 activates human trophoblasts to express IP-10 and IL-6: implications in the immunopathophysiology of preeclampsia. Mediators Inflamm (2014) 0.77
Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents. Front Pharmacol (2015) 0.77
Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy. Med J Obstet Gynecol (2013) 0.77
Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol (2016) 0.76
Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Eicosanoids and tumor necrosis factor-alpha in the kidney. Prostaglandins Other Lipid Mediat (2011) 0.76
Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stress. Am J Physiol Regul Integr Comp Physiol (2015) 0.75
Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol (2016) 0.75
Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response. Lab Invest (2014) 0.75
Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia. Curr Hypertens Rep (2016) 0.75
Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy. Expert Opin Ther Targets (2015) 0.75
Placental ischemia induces changes in gene expression in chorionic tissue. Mamm Genome (2014) 0.75
Identifying immune mechanisms mediating the hypertension during preeclampsia. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia. Int J Mol Sci (2017) 0.75
Dual regulation of tumor necrosis factor-α on myosin light chain phosphorylation in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2014) 0.75
Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats. J Hypertens (2016) 0.75
Enodthelin 1 is elevated in plasma and explants from patients having uterine leiomyomas. Reprod Sci (2014) 0.75
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Prog Mol Biol Transl Sci (2017) 0.75
The role of renal transporters and novel regulatory interactions in the TAL that control blood pressure. Physiol Genomics (2017) 0.75
Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol (2007) 2.70
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension (2007) 2.53
Birth centers in Australia: a national population-based study of perinatal mortality associated with giving birth in a birth center. Birth (2007) 2.27
The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens (2010) 2.23
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension (2006) 2.11
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension (2009) 2.00
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension (2005) 1.95
Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med (2006) 1.94
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension (2009) 1.82
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension (2008) 1.78
Admission of term infants to neonatal intensive care: a population-based study. Birth (2007) 1.77
Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust (2007) 1.76
Does size matter? A population-based study of birth in lower volume maternity hospitals for low risk women. BJOG (2006) 1.76
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension (2008) 1.72
Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension (2013) 1.71
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension (2008) 1.65
Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep (2007) 1.65
Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension (2006) 1.58
Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension (2009) 1.49
International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003. Fertil Steril (2011) 1.46
Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension (2008) 1.45
L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension (2004) 1.44
Capacity to monitor severe maternal morbidity in Australia. Aust N Z J Obstet Gynaecol (2008) 1.44
World collaborative report on in vitro fertilization, 2000. Fertil Steril (2006) 1.42
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens (2009) 1.41
Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens (2008) 1.38
Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol (2002) 1.36
Promotion of altruistic donation. Transplantation (2009) 1.33
An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol (2006) 1.31
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab (2009) 1.26
Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens (2007) 1.26
Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens (2011) 1.24
Tumor necrosis factor-alpha-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am J Hypertens (2002) 1.23
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med (2011) 1.22
Role of reactive oxygen species in endothelin-induced hypertension. Hypertension (2003) 1.21
Hypertension: physiology and pathophysiology. Compr Physiol (2012) 1.18
Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth (2012) 1.17
Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension (2011) 1.14
Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol (2010) 1.14
Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens (2011) 1.13
International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006. Hum Reprod (2014) 1.10
The ICMART glossary on ART terminology. Hum Reprod (2006) 1.09
Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med (2008) 1.07
Dietary salt enhances benzamil-sensitive component of myogenic constriction in mesenteric arteries. Am J Physiol Heart Circ Physiol (2007) 1.04
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Microscopic and histological examination of the mouse hindpaw digit and flexor tendon arrangement with 3D reconstruction. J Anat (2006) 1.03
Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation (2013) 1.03
Birth outcomes associated with interventions in labour amongst low risk women: a population-based study. Women Birth (2007) 1.03
Mechanisms and potential therapies for preeclampsia. Curr Hypertens Rep (2011) 1.02
Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressure. Am J Hypertens (2007) 1.02
Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol (2010) 1.00
The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology. Fertil Steril (2006) 0.99
Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.99
Inflammatory cytokines, vascular function, and hypertension. Am J Physiol Regul Integr Comp Physiol (2004) 0.99
Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol (2005) 0.97
Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.96
Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation. Int J Interferon Cytokine Mediat Res (2011) 0.96
Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α. Am J Physiol Regul Integr Comp Physiol (2012) 0.95
Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hypertens (2011) 0.95
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens (2009) 0.95
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants. Clin Cancer Res (2007) 0.94
Sildenafil attenuates placental ischemia-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2013) 0.94
Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. Hypertension (2012) 0.93
L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.93
Dominance of Mycoplasma in the guts of the Long-Jawed Mudsucker, Gillichthys mirabilis, from five California salt marshes. Environ Microbiol (2007) 0.92
Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens (2011) 0.91
Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.91
Focusing on children's inhalation dosimetry and health effects for risk assessment: an introduction. J Toxicol Environ Health A (2008) 0.90
An evaluation of a patient-reported outcomes found computerized adaptive testing was efficient in assessing osteoarthritis impact. J Clin Epidemiol (2006) 0.90
Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.88
Deposition, imaging, and clearance: what remains to be done? J Aerosol Med Pulm Drug Deliv (2010) 0.88
Endothelin-induced increases in Ca2+ entry mechanisms of vascular contraction are enhanced during high-salt diet. Hypertension (2002) 0.88
TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol (2002) 0.88
A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. Commun Dis Intell Q Rep (2010) 0.88
MotherSafe: review of three years of counselling by an Australian Teratology Information Service. Aust N Z J Obstet Gynaecol (2009) 0.87
Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens (2013) 0.87
Maternal deaths in New South Wales, Australia: a data linkage project. Aust N Z J Obstet Gynaecol (2008) 0.87
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol (2009) 0.86
Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens (2002) 0.86
Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens (2010) 0.86
Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Hypertension (2004) 0.86